EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden

Mathias M Petersen, Jakob Kleif, Lars N Jørgensen, Jakob W Hendel, Jakob B Seidelin, Mogens R Madsen, Jesper Vilandt, Søren Brandsborg, Jørn S Rasmussen, Lars M Andersen, Ali Khalid, Linnea Ferm und 7 weitere

Clinical Colorectal Cancer · 2023

DOI: 10.1016/j.clcc.2023.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2023. Verfasst von Mathias M Petersen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Gastro Unit, Hvidovre Hospital, Hvidovre, Denmark; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address…. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Augustinus Fonden, Dansk Kræftforsknings Fond, Hans og Nora Buchards Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fecal Immunochemical Test (FIT) is widely used in population-based screening for colorectal cancer (CRC). This had led to major challenges regarding colonoscopy capacity. Methods to maintain high sensitivity without compromising the colonoscopy capacity are needed. This study investigates an algorithm that combines FIT result, blood-based biomarkers associated with CRC, and individual demographics, to triage subjects sent for colonoscopy among a FIT positive (FIT+) screening population and thereby reduce the colonoscopy burden. MATERIALS AND METHODS: From the Danish National Colorectal Cancer Screening Program, 4048 FIT+ (≥100 ng/mL Hemoglobin) subjects were included and analyzed for a panel of 9 cancer-associated biomarkers using the ARCHITECT i2000. Two algorithms were developed: 1) a predefined algorithm based on clinically available biomarkers: FIT, age, CEA, hsCRP and Ferritin; and 2) an exploratory algorithm adding additional biomarkers: TIMP-1, Pepsinogen-2, HE4, CyFra21-1, Galectin-3, B2M and sex to the predefined algorithm. The diagnostic performances for discriminating subjects with or without CRC in the 2 models were benchmarked against the FIT alone using logistic regression modeling. RESULTS: The discrimination of CRC showed an area under the curve (AUC) of 73.7 (70.5-76.9) for the predefined model, 75.3 (72.1-78.4) for the exploratory model, and 68.9 (65.5-72.2) for FIT alone. Both models performed significantly better (P < .001) than the FIT model. The models were benchmarked vs. FIT at cutoffs of 100, 200, 300, 400, and 500 ng/mL Hemoglobin using corresponding numbers of true positives and false positives. All performance metrics were improved at all cutoffs. CONCLUSION: A screening algorithm including a combination of FIT result, blood-based biomarkers and demographics outperforms FIT in discriminating subjects with or without CRC in a screening population with FIT results above 100 ng/mL Hemoglobin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerColorectal NeoplasmsHumansHemoglobinsOccult BloodBiomarkers, TumorColonoscopyFecesDemographyHematologic TestsMass ScreeningAntigens, NeoplasmKeratin-19

Stichwörter der Autor:innen

BiomarkersColorectal neoplasiaEarly detectionLogistic regression modelingMinimal invasive liquid biopsy

Substanzen

HemoglobinsBiomarkers, Tumorantigen CYFRA21.1Antigens, NeoplasmKeratin-19

Autor:innen und Institutionen

  • Gastro Unit, Hvidovre Hospital, Hvidovre, Denmark; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: mathias.mertz.petersen@regionh.dk.
  • Gastro Unit, Hvidovre Hospital, Hvidovre, Denmark; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Surgery, Nordsjællands Hospital, Hillerød, Denmark.
  • Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Digestive Disease Center, Bispebjerg Hospital, Copenhagen, Denmark.
  • Gastro Unit, Section for Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Department of Surgery, Herning Hospital, Herning, Denmark.
  • Department of Surgery, Nordsjællands Hospital, Hillerød, Denmark.

Förderung

  • Augustinus Fonden
  • Dansk Kræftforsknings Fond
  • Hans og Nora Buchards Fond
  • Vissing Fonden
  • Aase og Ejnar Danielsens Fond
  • Arvid Nilssons Fond
  • Minister Erna Hamilton&apos;s Scholarship for Science and Art
  • Toyota Foundation

Zitieren

APA

Petersen, M. M., Kleif, J., Jørgensen, L. N., Hendel, J. W., Seidelin, J. B., Madsen, M. R., Vilandt, J., Brandsborg, S., Rasmussen, J. S., Andersen, L. M., Khalid, A., Ferm, L., Gawel, S. H., Martens, F., Andersen, B., Rasmussen, M., Davis, G. J., Christensen, I. J., & Therkildsen, C. (2023). Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2023.02.001

Vancouver

Petersen MM, Kleif J, Jørgensen LN, Hendel JW, Seidelin JB, Madsen MR, et al. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden. Clinical Colorectal Cancer. 2023. doi:10.1016/j.clcc.2023.02.001

BibTeX
@article{Petersen2023,
  author = {Petersen, Mathias M and Kleif, Jakob and Jørgensen, Lars N and Hendel, Jakob W and Seidelin, Jakob B and Madsen, Mogens R and Vilandt, Jesper and Brandsborg, Søren and Rasmussen, Jørn S and Andersen, Lars M and Khalid, Ali and Ferm, Linnea and Gawel, Susan H and Martens, Frans and Andersen, Berit and Rasmussen, Morten and Davis, Gerard J and Christensen, Ib J and Therkildsen, Christina},
  title = {Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden},
  journal = {Clinical Colorectal Cancer},
  year = {2023},
  doi = {10.1016/j.clcc.2023.02.001}
}
Kostenlos starten →